Neptune Technologies & Bioresources
The 10-second takeaway
For the quarter ended Nov. 30 (Q3), Neptune Technologies & Bioresources met expectations on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded significantly and GAAP loss per share expanded.
Margins dropped across the board.
Neptune Technologies & Bioresources logged revenue of $7.1 million. The one analyst polled by S&P Capital IQ anticipated sales of $7.1 million on the same basis. GAAP reported sales were 41% higher than the prior-year quarter's $5.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.21. The one earnings estimate compiled by S&P Capital IQ predicted $0.00 per share. GAAP EPS were -$0.21 for Q3 versus -$0.01 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 47.5%, 570 basis points worse than the prior-year quarter. Operating margin was -52.8%, 1,640 basis points worse than the prior-year quarter. Net margin was -166.0%, 15,610 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $2.0 million.
Next year's average estimate for revenue is $23.4 million. The average EPS estimate is -$0.12.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 27 members out of 152 rating the stock outperform, and 125 members rating it underperform. Among 83 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), four give Neptune Technologies & Bioresources a green thumbs-up, and 79 give it a red thumbs-down.
Looking for alternatives to Neptune Technologies & Bioresources? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Neptune Technologies & Bioresources to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.